OVEREXPRESSION OF PROSTATE-SPECIFIC TMPRSS2(EXON 0)-ERG FUSION TRANSCRIPTS CORRESPONDS WITH FAVORABLE PROGNOSIS OF PROSTATE CANCER

被引：0
|
作者：
Boormans, Joost
Hermans, Karin G.
van Leenders, Geert J.
Uerhagen, Paul C.
Trapman, Jan
机构：
来源：
JOURNAL OF UROLOGY | 2009年 / 181卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(09)60743-6
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
729
引用
收藏
页码：261 / 261
页数：1
相关论文
共 50 条
  • [31] Overexpression of truncated ERG from TMPRSS2-ERG fusion and prostate cancer development
    Leong, Melanie
    Shi, Wen-Feng
    Tian, Jun
    Cho, Ellen
    Raza, Abbas
    Siddiqi, Saquib A.
    Selim, Abdulhafez
    Chen, Han-Chun
    Zhang, Dianzheng
    PATHOLOGY AND LABORATORY MEDICINE INTERNATIONAL, 2009, 1 : 13 - 21
  • [32] Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome
    Yoshimoto, Maisa
    Joshua, Anthony M.
    Cunha, Isabela W.
    Coudry, Renata A.
    Fonseca, Francisco P.
    Ludkovski, Olga
    Zielenska, Maria
    Soares, Fernando A.
    Squire, Jeremy A.
    MODERN PATHOLOGY, 2008, 21 (12) : 1451 - 1460
  • [33] TMPRSS2:ERG fusion enhances osteoblastic phenotype of prostate cancer bone metastases
    Delliaux, Carine
    Tian, V. Tian
    Bouchet, Mathilde
    Fradet, Anais
    Vanpouille, Nathalie
    Flourens, Anne
    Deplus, Rachel
    Leroy, Xavier
    de Launoit, Yvan
    Bonnelye, Edith
    Duterque-Coquillaud, Martine
    CANCER RESEARCH, 2016, 76
  • [34] Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer
    G Attard
    J Clark
    L Ambroisine
    G Fisher
    G Kovacs
    P Flohr
    D Berney
    C S Foster
    A Fletcher
    W L Gerald
    H Moller
    V Reuter
    J S De Bono
    P Scardino
    J Cuzick
    C S Cooper
    Oncogene, 2008, 27 : 253 - 263
  • [35] Etiology of prostate cancer with the TMPRSS2:ERG fusion: A systematic review of risk factors
    Mcgrath, Colleen B.
    Shreves, Alaina H.
    Shanahan, Megan R.
    Guard, Hannah E.
    Nhliziyo, Manelisi V.
    Pernar, Claire H.
    Penney, Kathryn L.
    Lotan, Tamara L.
    Fiorentino, Michelangelo
    Mucci, Lorelei A.
    Stopsack, Konrad H.
    INTERNATIONAL JOURNAL OF CANCER, 2024,
  • [36] Dual TMPRSS2:ERG Fusion in a Patient with Lung and Prostate Cancers
    Giunchi, Francesca
    Massari, Francesco
    Altimari, Annalisa
    Gruppioni, Elisa
    Nobili, Elisabetta
    Fiorentino, Michelangelo
    Ardizzoni, Andrea
    DIAGNOSTICS, 2020, 10 (12)
  • [37] TMPRSS2:ERG gene fusion -: A new genetic marker for prostate cancer progression
    Macaluso, Marcella
    Giordano, Antonio
    CANCER BIOLOGY & THERAPY, 2007, 6 (01) : 46 - 47
  • [38] Precision prevention of TMPRSS2: ERG prostate cancer.
    Mucci, Lorelei A.
    Ahearn, Thomas
    Penney, Kathryn
    Pettersson, Andreas
    Graff, Rebecca E.
    Kantoff, Philip W.
    Finn, Stephen
    Loda, Massimo
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [39] Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer
    Attard, G.
    Clark, J.
    Ambroisine, L.
    Fisher, G.
    Kovacs, G.
    Flohr, P.
    Berney, D.
    Foster, C. S.
    Fletcher, A.
    Gerald, W. L.
    Moller, H.
    Reuter, V.
    De Bono, J. S.
    Scardino, P.
    Cuzick, J.
    Cooper, C. S.
    ONCOGENE, 2008, 27 (03) : 253 - 263
  • [40] Association of common genetic variants with TMPRSS2 ERG fusion status in prostate cancer
    Kohaar, Indu
    Ravindranath, Lakshmi
    Young, Denise
    Ali, Amina
    Li, Qiyuan
    Dobi, Albert
    McLeod, David
    Rosner, Inger L.
    Sesterhenn, Isabell
    Freedman, Matthew
    Srivastava, Shiv
    Petrovics, Gyorgy
    CANCER RESEARCH, 2017, 77
12345